161 related articles for article (PubMed ID: 31928012)
1. Proteomic Analysis of MYB-Regulated Secretome Identifies Functional Pathways and Biomarkers: Potential Pathobiological and Clinical Implications.
Zubair H; Patel GK; Khan MA; Azim S; Zubair A; Singh S; Srivastava SK; Singh AP
J Proteome Res; 2020 Feb; 19(2):794-804. PubMed ID: 31928012
[TBL] [Abstract][Full Text] [Related]
2. MYB is a novel regulator of pancreatic tumour growth and metastasis.
Srivastava SK; Bhardwaj A; Arora S; Singh S; Azim S; Tyagi N; Carter JE; Wang B; Singh AP
Br J Cancer; 2015 Dec; 113(12):1694-703. PubMed ID: 26657649
[TBL] [Abstract][Full Text] [Related]
3. MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin.
Bhardwaj A; Srivastava SK; Singh S; Tyagi N; Arora S; Carter JE; Khushman M; Singh AP
J Biol Chem; 2016 Jul; 291(31):16263-70. PubMed ID: 27246849
[TBL] [Abstract][Full Text] [Related]
4. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.
Azim S; Zubair H; Srivastava SK; Bhardwaj A; Zubair A; Ahmad A; Singh S; Khushman M; Singh AP
Sci Rep; 2016 Jun; 6():28446. PubMed ID: 27354262
[TBL] [Abstract][Full Text] [Related]
5. Proteome and secretome analysis of pancreatic cancer cells.
Li X; Liu H; Dun MD; Faulkner S; Liu X; Jiang CC; Hondermarck H
Proteomics; 2022 Jul; 22(13-14):e2100320. PubMed ID: 35388624
[TBL] [Abstract][Full Text] [Related]
6. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.
Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F
Oncotarget; 2016 Feb; 7(5):5598-612. PubMed ID: 26734996
[TBL] [Abstract][Full Text] [Related]
8. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium.
Liu P; Weng Y; Sui Z; Wu Y; Meng X; Wu M; Jin H; Tan X; Zhang L; Zhang Y
Sci Rep; 2016 Nov; 6():37606. PubMed ID: 27869176
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.
Principe S; Mejia-Guerrero S; Ignatchenko V; Sinha A; Ignatchenko A; Shi W; Pereira K; Su S; Huang SH; O'Sullivan B; Xu W; Goldstein DP; Weinreb I; Ailles L; Liu FF; Kislinger T
J Proteome Res; 2018 Jun; 17(6):2045-2059. PubMed ID: 29681158
[TBL] [Abstract][Full Text] [Related]
11. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
12. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells.
Rencuzogulları O; Yerlikaya PO; Gürkan AÇ; Arısan ED; Telci D
J Cell Biochem; 2020 Jan; 121(1):508-523. PubMed ID: 31264276
[TBL] [Abstract][Full Text] [Related]
13. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
[TBL] [Abstract][Full Text] [Related]
14. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
[TBL] [Abstract][Full Text] [Related]
15. The secretome signature of malignant mesothelioma cell lines.
Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
[TBL] [Abstract][Full Text] [Related]
18. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
19. In silico approach to predict pancreatic β-cells classically secreted proteins.
Pinheiro-Machado E; Milkewitz Sandberg TO; Pihl C; Hägglund PM; Marzec MT
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003782
[TBL] [Abstract][Full Text] [Related]
20. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
